News > Biotechnology

06th December 2019

Winners announced for MediWales Innovation Awards

Winners have been announced at the fourteenth annual MediWales Innovation Awards, which celebrate outstanding achievements in NHS Wales and in the Welsh life science and health technology communities.
14th November 2019

New advanced therapy for endometrial cancer granted US patent

Swansea University scientists’ hard work in the fight against endometrial cancer has seen them being granted a US patent for pioneering new therapy. Professor Deya Gonzalez and Professor Steve Conlan, of Swansea University Medical School’s Reproductive Biology and Gynaecological Oncology group, developed a method of treating gynaecological cancer which it is hoped will minimise side…

13th November 2019

Green light for BEACON project boosts Wales’ bio economy

The Counsel General and Brexit Minister, Jeremy Miles, visited Aberystwyth University today to open the new Bio-refining Centre and Seed Biobank buildings at the University’s Innovation and Enterprise Campus. Mr Miles, who is responsible for EU funding in Wales, announced a £3.7 million EU investment to extend the award-winning BEACON bio economy programme, led by…

22nd October 2019

University highlights global issues at first bioethics conference

Academics, students and health professionals gathered tackle some of today’s most pressing ethical issues at a special conference at Swansea University. Held to mark World Bioethics Day, the event featured a diverse programme of topics on a variety of topical themes including mental health, maternity care, climate change and cultural diversity. Bioethics is the study…

14th October 2019

University gives pupils first-hand experience of nanotechnology

Pupils have been given an unique opportunity to find out more about nanotechnology at a special Swansea University workshop aimed at inspiring scientists of the future. NanoBach brought Year 7 & 8 pupils from across Neath Port Talbot together with students who were able to demonstrate what nanotechnology is and how it can be applied…

30th September 2019

Launch of the World BioProtection Forum signals new era of industry and academic co-operation in agri-biocontrol

The industry body will foster innovation and commercialisation of environmentally friendly super-sector A new non-profit organisation launches today with the goal of furthering innovation and collaboration within the bioprotection market, and to speed the path to commercialisation. Biological solutions for the control ofpests and diseases is a fast-growing segment of AgriTech and offers a sustainable…

30th September 2019

Jellyfish collagen set to revolutionise in vitro cell culture and tissue engineering

Jellagen® launches their first purified jellyfish collagen hydrogel: JellaGelTM Jellyfish’s unique physiology means its collagen has distinct advantages over mammal-derived and synthetic materials Batch-to-batch consistency of jellyfish collagen can greatly improve lab management JellaGelTM, jellyfish collagen hydrogel, suitable for 3D cell culture and tissue engineering launches today to offer a solution to different challenges facing…

03rd September 2019

Indoor Biotechnologies Update

Summer is winding down, but Indoor Biotechnologies is moving into fall with several exciting announcements.Indoor Biotechnologies is delighted to announce that it has recently signed a patent license agreement with Biomay AG (Vienna, Austria) to cover sales of monoclonal antibody-based immunoassays for mite allergen Der p 23 on its ELISA 2.0 and MARIA® platforms.This strategic partnership gives…

05th August 2019

Expert Advice: The Expanding Molecular Diagnostic Approach in Cancer Treatment

Over the past decade, genetic testing has become an essential component of the management of solid and hematologic cancers. It is estimated that 50-90% of tumours bear one or more ‘actionable’ mutations, which could be targeted with either EMA-approved or experimental drugs. As new technologies allow for more and more genes to be tested simultaneously…

22nd July 2019

Swansea University researcher wins £60,000 funding to aid biomaterial research

A researcher at Swansea University working with AgorIP is the third person in the institution’s history to win funding from the Royal Academy of Engineering. Dr Jonathan Widdowson, 26, who is also the CEO of company ProColl, won the funding of £60,000 that will aid their mission to supply biomaterials to help researchers create innovations…